| Literature DB >> 15633473 |
Abstract
Although male breast cancer (MBC) is rare (<1% of all BC), its reported incidence has been rising. In addition to traditional risk factors, there is now known to be a 7% life-time risk in carriers of BRCA2. This article discusses the clinical and histological presentation of MBC and reviews the main treatments.Entities:
Mesh：
Year: 2004 PMID： 15633473
Source DB: PubMed Journal: Int J Fertil Womens Med ISSN： 1534-892X